Delivery Order SPE2DB22D3011-SPE2DB24FQ1PM

Award Date 5/29/24
Potential Completion Date 5/30/24
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $1,187.55 firm fixed price delivery order contract to Amerisourcebergen Drug Corporation's Corporate Office Division to supply 4,564,361,392 units of the prescription medication Eliquis 2.5 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a $17,821.43 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Eliquis 5 mg tablets. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a $3,800.16 firm-fixed price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of Eliquis 2.5 mg tablets, with a period of performance through April 18, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $8,496.72 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Eliquis 5 mg tablets. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen Drug Corp holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $16,544.69 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Eliquis 5 mg tablets and has an ultimate completion date of January 3, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $1,743.83 contract is for the supply of 60 tablets of the prescription drug Eliquis 5 mg, with a completion date of March 7, 2024. This order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that...
The U.S. Defense Logistics Agency (DLA) awarded a $11,775.99 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Eliquis 5 mg tablets. This order falls under Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical, which enables the agency to efficiently procure a wide range of pharmaceutical products and medical supplies for the Department of Defense worldwide....
The U.S. Department of Defense's Defense Logistics Agency (DLA) has awarded a delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Eliquis 5 mg tablets. The contract has a firm fixed price of $14,704.21 and a performance period through April 9, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of up to $999,999,999.00 and a...
The U.S. Defense Logistics Agency (DLA) awarded a $2,543.96 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Eliquis 5 mg tablets. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical and medical supplies to support military healthcare programs globally. The contract has no...
The U.S. government awarded a $2,495.97 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is for the supply of Eliquis 5 mg tablets. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, which serves as a primary vehicle for providing a...
  • SPE2DB22D3011
    Indefinite Delivery Contract
  • SPE2DB22D3011-SPE2DB24FQ1PM
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a major pharmaceutical distributor, a Firm Fixed Price Delivery Order contract worth $16,038.79 for the supply of Eliquis 5 mg tablets. This award is a part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. Under this IDC, Amerisourcebergen provides a wide range of pharmaceutical products and medical supplies to support the Department of Defense's medical treatment programs and facilities globally. The contract does not have a set-aside designation, indicating it was awarded on a full and open competition basis. Amerisourcebergen, through its Corporate Office Division, is well-positioned to fulfill this order due to its extensive pharmaceutical distribution capabilities and existing supply relationships with the federal government.

Generated 8/28/24, 11:17 AM